In March, AIM Specialty Health® to update clinical guidelines for prostate cancer imaging
Starting March 13, 2022, AIM Specialty Health will publish updated oncologic imaging clinical guidelines for prostate cancer to include indications for 18FDCFPyL (piflufolastat injection or Pylarify®) PET/CT imaging (radiology procedure code *78815).
In the future, these scans will be available for you to select when you submit prior authorizations requests to AIM.
Until you are able to select these scans, use the “free text” field in the prior authorization request and:
This applies to the following members:
Where to find AIM's clinical guidelines
You can find AIM's clinical guidelines for oncologic management at aimspecialtyhealth.com/**. Open the Radiology Guidelines webpage and search for “Oncologic Imaging.” Then scroll to find the Prostate Cancer guidelines.
Submitting prior authorization requests
Submit prior authorization requests to AIM. For information on how to submit requests and for other resources, visit these webpages on our ereferrals.bcbsm.com website:
*CPT Copyright 2020 American Medical Association. All rights reserved. CPT® is a registered trademark of the American Medical Association.
**Clicking this link means you’re leaving the Blue Cross Blue Shield of Michigan and Blue Care Network website. While we recommend this site, we’re not responsible for its content.
Posted: December 2021
Lines of business: Blue Cross Blue Shield of Michigan and Blue Care Network